These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2633930)

  • 1. Hemodynamic effects of mexiletine and disopyramide after cardioplegic arrest.
    Moritz A; Eckersberger F; Losert U; Probst P; Schreiner W; Wolner E
    Eur Surg Res; 1989; 21(6):327-35. PubMed ID: 2633930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systolic time intervals in evaluation of the negative inotropic effect after single oral doses of mexiletine and disopyramide.
    Rousson D; Piolat C; Galleyrand J; Ferry S; Boissel JP
    Eur J Clin Pharmacol; 1986; 30(3):263-8. PubMed ID: 3732360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic, electrocardiographic and toxic effects of the intravenous administration of increasing doses of mexiletine in the dog. Comparison with similar effects produced by other antiarrhythmics.
    Carlier J
    Acta Cardiol Suppl; 1980; (25):81-100. PubMed ID: 6966456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative haemodynamic effects of lidocaine, mexiletine, and disopyramide.
    Beltrame J; Aylward PE; McRitchie RJ; Chalmers JP
    J Cardiovasc Pharmacol; 1984; 6(3):483-90. PubMed ID: 6202976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemodynamic effects of disopyramide on postischemic and normal myocardium].
    Hoffmeister HM; Hörmann HP; Beyer M; Seipel L
    Klin Wochenschr; 1990 Dec; 68(23):1178-82. PubMed ID: 2280581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of anti-arrhythmic drugs on myocardial function (author's transl)].
    Wester HA; Mouselimis N
    Dtsch Med Wochenschr; 1982 Aug; 107(34):1262-6. PubMed ID: 6809442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of moricizine on reperfusion induced tachyarrhythmias in rats--a comparison study with disopyramide and mexiletine.
    He ZS; Komori S; Tamura K; Hashimoto K
    Jpn Circ J; 1992 Aug; 56(8):861-5. PubMed ID: 1527898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of disopyramide and mexiletine on the terminal repolarization process of the in situ heart assessed using the halothane-anesthetized in vivo canine model.
    Yoshida H; Sugiyama A; Satoh Y; Ishida Y; Kugiyama K; Hashimoto K
    Circ J; 2002 Sep; 66(9):857-62. PubMed ID: 12224826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative studies on the cardiodepressant effect of disopyramide, mexiletine and propafenon].
    Angermann C; Jahrmärker H
    Z Kardiol; 1983 Nov; 72(11):665-74. PubMed ID: 6659643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SC-36602, a new antiarrhythmic agent: comparison of its cardiovascular profile with that of other antiarrhythmic drugs.
    Frederick LG; Hatley FR; McDonald SJ; Stamm MH; Garthwaite SM
    J Cardiovasc Pharmacol; 1988 Jun; 11(6):657-66. PubMed ID: 2457760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic effects of disopyramide in patients after open-heart surgery.
    Naqvi N; Thompson DS; Morgan WE; Williams BT; Coltart DJ
    Br Heart J; 1979 Nov; 42(5):587-94. PubMed ID: 316334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the electrophysiological effects of Org 7797, disopyramide, mexiletine and propafenone in anaesthetized dogs with myocardial infarcts.
    Campbell JK; Marshall RJ; Winslow E
    Br J Pharmacol; 1991 Oct; 104(2):433-9. PubMed ID: 1797309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coupling interval-related effects of class I antiarrhythmic drugs, mexiletine, cibenzoline and disopyramide, on ventricular activation in canine myocardial infarction.
    Hashimoto H; Satoh N; Nakashima M
    Jpn J Pharmacol; 1991 Dec; 57(4):463-72. PubMed ID: 1803064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic, hemodynamic, and electrocardiographic responses to increased circulating adrenaline: effects of pretreatment with class 1 antiarrhythmics.
    Hansen O; Johansson BW; Gullberg B
    Angiology; 1991 Dec; 42(12):990-1001. PubMed ID: 1763833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncorrected pre-ejection period: a simple non-invasive measurement for pharmacodynamic screening of inotropic activity.
    Rousson D; Galleyrand J; Silie M; Boissel JP
    Eur J Clin Pharmacol; 1987; 31(5):559-62. PubMed ID: 3830241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of the negative inotropic effect of disopyramide.
    Kenedi PP
    J Int Med Res; 1988; 16(4):257-63. PubMed ID: 3169371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of disopyramide on the electrocardiogram and ventricular function in the unanesthetized dog.
    Crosby HH; Hamlin RL; Strauch SM
    J Vet Pharmacol Ther; 1984 Sep; 7(3):167-75. PubMed ID: 6492243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemodynamic effects of mexiletine].
    Vallot F; Page A; Besse P
    Arch Mal Coeur Vaiss; 1979 Dec; 72(12):1359-66. PubMed ID: 120153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intropic effects of several antiarrhythmic drugs.
    Ferro G; Chiariello M; Tari MG; Vigorito C; Ungaro B; Condorelli M
    Jpn Heart J; 1983 May; 24(3):377-90. PubMed ID: 6876382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
    Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T
    Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.